Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Qifeng Yang

Showing results (1-10 of 342) with videos related to

Pageof 35
Sort By:
Clinical Breast Cancer|December 9, 2004
Is bcl-2 useful to select endocrine therapy for breast cancer?Qifeng Yang
Medical Hypotheses|June 13, 2009
Primary tumor resection may improve prognosis for nonoperable advanced breast cancerNing Zhang, Qifeng Yang
Oncology Letters|August 7, 2012
Astrocyte elevated gene-1 and breast cancer (Review)Chuan Wang, Qifeng Yang
Medical Hypotheses|June 7, 2011
P53-binding protein 1: a new player for tumorigenesis and a new target for breast cancer treatmentQiang Huo, Qifeng Yang
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|August 8, 2018
Bioinformatics-based interaction analysis of miR-92a-3p and key genes in tamoxifen-resistant breast cancer cellsJinjing Cun, Qifeng Yang
Molecular Medicine Reports|March 18, 2016
rs621554 single nucleotide polymorphism of DLC1 is associated with breast cancer susceptibility and prognosisXia Ding, Sumei Gao, Qifeng Yang
Oncology Research and Treatment|October 25, 2014
Rural-urban disparities contributed to distinct outcomes of early stage breast cancerQiang Huo, Chang Cai, Qifeng Yang
BMC Cancer|December 13, 2017
The prognosis of invasive micropapillary carcinoma compared with invasive ductal carcinoma in the breast: a meta-analysisYun Wu, Ning Zhang, Qifeng Yang
Pathology International|April 26, 2002
Predictive and prognostic markers for invasive breast cancerIchiro Mori, Qifeng Yang, Kennichi Kakudo
Diagnostic Pathology|June 23, 2010
Immunohistochemical analysis of Metadherin in proliferative and cancerous breast tissuePeng Su, Qinghui Zhang, Qifeng Yang
Pageof 35

Showing results (1-10 of 342) with videos related to

Sort By:
Pageof 35
Clinical Breast Cancer|December 9, 2004
Is bcl-2 useful to select endocrine therapy for breast cancer?Qifeng Yang
Medical Hypotheses|June 13, 2009
Primary tumor resection may improve prognosis for nonoperable advanced breast cancerNing Zhang, Qifeng Yang
Oncology Letters|August 7, 2012
Astrocyte elevated gene-1 and breast cancer (Review)Chuan Wang, Qifeng Yang
Medical Hypotheses|June 7, 2011
P53-binding protein 1: a new player for tumorigenesis and a new target for breast cancer treatmentQiang Huo, Qifeng Yang
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|August 8, 2018
Bioinformatics-based interaction analysis of miR-92a-3p and key genes in tamoxifen-resistant breast cancer cellsJinjing Cun, Qifeng Yang
Molecular Medicine Reports|March 18, 2016
rs621554 single nucleotide polymorphism of DLC1 is associated with breast cancer susceptibility and prognosisXia Ding, Sumei Gao, Qifeng Yang
Oncology Research and Treatment|October 25, 2014
Rural-urban disparities contributed to distinct outcomes of early stage breast cancerQiang Huo, Chang Cai, Qifeng Yang
BMC Cancer|December 13, 2017
The prognosis of invasive micropapillary carcinoma compared with invasive ductal carcinoma in the breast: a meta-analysisYun Wu, Ning Zhang, Qifeng Yang
Pathology International|April 26, 2002
Predictive and prognostic markers for invasive breast cancerIchiro Mori, Qifeng Yang, Kennichi Kakudo
Diagnostic Pathology|June 23, 2010
Immunohistochemical analysis of Metadherin in proliferative and cancerous breast tissuePeng Su, Qinghui Zhang, Qifeng Yang
Pageof 35